2025
Development and Validation of a Rapid and Simple UHPLC-MS/MS Method for the Determination of Colchicine in Human Plasma
ZIDEKOVA, Nela; Kristian PRSO; Marek PRSO; Milos JESENAK; Oldřich FARSA et al.Základní údaje
Originální název
Development and Validation of a Rapid and Simple UHPLC-MS/MS Method for the Determination of Colchicine in Human Plasma
Autoři
ZIDEKOVA, Nela; Kristian PRSO; Marek PRSO; Milos JESENAK; Oldřich FARSA ORCID a Martin KERTYS
Vydání
BIOMEDICAL CHROMATOGRAPHY, HOBOKEN, WILEY, 2025, 0269-3879
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.700 v roce 2024
Označené pro přenos do RIV
Ano
Organizační jednotka
Farmaceutická fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
colchicine; familial Mediterranean fever; liquid chromatography-tandem mass spectrometry; phospholipid removal; therapeutic drug monitoring
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 11. 3. 2026 14:57, Mgr. Irena Doubková
Anotace
V originále
Colchicine is a naturally occurring alkaloid primarily derived from plants of the Colchicum genus, which is used to treat gout and serve as a frontline therapy for various inflammatory conditions, including familial Mediterranean fever. Although it is not recommended for routine therapeutic drug monitoring, there are situations where it may be beneficial, such as in dose adjustments. The present study introduces an LC-MS/MS method for quantifying colchicine in human plasma. A one-step extraction procedure employing an Ostro plate was applied, and the extracts were analyzed using gradient elution followed by detection on a mass spectrometer in multiple reaction monitoring mode. Our method offers several advantages, including a low sample volume and a run time of only 3 min. It demonstrates sufficient linearity to quantify low and high concentrations of colchicine in human plasma samples. The method was successfully validated in accordance with the ICH guideline M10 on bioanalytical method validation, covering selectivity, linearity, limit of quantification, accuracy, precision, dilution integrity, carry-over effect, matrix effects, extraction recovery, and stability over a concentration range of 0.05-100 ng/mL. The fully developed and validated method was applied to determine colchicine in plasma samples from patients diagnosed with familial Mediterranean fever.